CME GROUP INC (CME) Fundamental Analysis & Valuation

NASDAQ:CME • US12572Q1058

Current stock price

302.81 USD
-7.77 (-2.5%)
At close:
302.81 USD
0 (0%)
After Hours:

This CME fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CME Profitability Analysis

1.1 Basic Checks

  • CME had positive earnings in the past year.
  • CME had a positive operating cash flow in the past year.
  • In the past 5 years CME has always been profitable.
  • CME had a positive operating cash flow in each of the past 5 years.
CME Yearly Net Income VS EBIT VS OCF VS FCFCME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • The Return On Assets of CME (2.03%) is comparable to the rest of the industry.
  • CME has a better Return On Equity (14.00%) than 71.13% of its industry peers.
  • CME has a better Return On Invested Capital (20.13%) than 95.82% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CME is significantly above the industry average of 7.24%.
  • The last Return On Invested Capital (20.13%) for CME is above the 3 year average (18.73%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.03%
ROE 14%
ROIC 20.13%
ROA(3y)2.34%
ROA(5y)1.97%
ROE(3y)13.02%
ROE(5y)11.7%
ROIC(3y)18.73%
ROIC(5y)14.69%
CME Yearly ROA, ROE, ROICCME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CME's Profit Margin of 32.81% is fine compared to the rest of the industry. CME outperforms 79.08% of its industry peers.
  • In the last couple of years the Profit Margin of CME has declined.
  • With an excellent Operating Margin value of 81.31%, CME belongs to the best of the industry, outperforming 98.74% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CME has grown nicely.
Industry RankSector Rank
OM 81.31%
PM (TTM) 32.81%
GM N/A
OM growth 3Y4.02%
OM growth 5Y7.87%
PM growth 3Y-3.77%
PM growth 5Y-4.62%
GM growth 3YN/A
GM growth 5YN/A
CME Yearly Profit, Operating, Gross MarginsCME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CME Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CME has been increased compared to 1 year ago.
  • The number of shares outstanding for CME has been increased compared to 5 years ago.
  • Compared to 1 year ago, CME has an improved debt to assets ratio.
CME Yearly Shares OutstandingCME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CME Yearly Total Debt VS Total AssetsCME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • CME has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
  • CME has a better Debt to FCF ratio (0.82) than 89.12% of its industry peers.
  • CME has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • CME's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. CME outperforms 79.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.82
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CME Yearly LT Debt VS Equity VS FCFCME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that CME should not have too much problems paying its short term obligations.
  • The Current ratio of CME (1.03) is comparable to the rest of the industry.
  • A Quick Ratio of 1.03 indicates that CME should not have too much problems paying its short term obligations.
  • CME has a Quick ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
CME Yearly Current Assets VS Current LiabilitesCME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CME Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.26% over the past year.
  • The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
  • The Revenue has grown by 20.06% in the past year. This is a very strong growth!
  • The Revenue has been growing by 19.33% on average over the past years. This is quite good.
EPS 1Y (TTM)9.26%
EPS 3Y12%
EPS 5Y10.74%
EPS Q2Q%9.92%
Revenue 1Y (TTM)20.06%
Revenue growth 3Y19.31%
Revenue growth 5Y19.33%
Sales Q2Q%8.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.89% on average over the next years.
  • CME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.78% yearly.
EPS Next Y7.52%
EPS Next 2Y6.94%
EPS Next 3Y7.53%
EPS Next 5Y4.89%
Revenue Next Year7.38%
Revenue Next 2Y6%
Revenue Next 3Y6.11%
Revenue Next 5Y4.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CME Yearly Revenue VS EstimatesCME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
CME Yearly EPS VS EstimatesCME Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. CME Valuation Analysis

4.1 Price/Earnings Ratio

  • CME is valuated quite expensively with a Price/Earnings ratio of 27.01.
  • Based on the Price/Earnings ratio, CME is valued a bit more expensive than 73.64% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, CME is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 25.12, the valuation of CME can be described as expensive.
  • Based on the Price/Forward Earnings ratio, CME is valued a bit more expensive than 65.69% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.69. CME is around the same levels.
Industry RankSector Rank
PE 27.01
Fwd PE 25.12
CME Price Earnings VS Forward Price EarningsCME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CME is valued cheaply inside the industry as 85.77% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CME is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.9
EV/EBITDA 10.43
CME Per share dataCME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of CME may justify a higher PE ratio.
PEG (NY)3.59
PEG (5Y)2.51
EPS Next 2Y6.94%
EPS Next 3Y7.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CME Dividend Analysis

5.1 Amount

  • CME has a Yearly Dividend Yield of 1.72%.
  • Compared to an average industry Dividend Yield of 6.89, CME is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.89, CME has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

  • The dividend of CME is nicely growing with an annual growth rate of 13.12%!
  • CME has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of CME decreased recently.
Dividend Growth(5Y)13.12%
Div Incr Years1
Div Non Decr Years1
CME Yearly Dividends per shareCME Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

5.3 Sustainability

  • 97.81% of the earnings are spent on dividend by CME. This is not a sustainable payout ratio.
  • CME's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP97.81%
EPS Next 2Y6.94%
EPS Next 3Y7.53%
CME Yearly Income VS Free CF VS DividendCME Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
CME Dividend Payout.CME Dividend Payout, showing the Payout Ratio.CME Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CME Fundamentals: All Metrics, Ratios and Statistics

CME GROUP INC

NASDAQ:CME (4/8/2026, 8:24:13 PM)

After market: 302.81 0 (0%)

302.81

-7.77 (-2.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-22
Inst Owners92.17%
Inst Owner Change0%
Ins Owners0.24%
Ins Owner Change0.91%
Market Cap108.59B
Revenue(TTM)12.26B
Net Income(TTM)4.02B
Analysts69
Price Target316.44 (4.5%)
Short Float %1.56%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend10.92
Dividend Growth(5Y)13.12%
DP97.81%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-10
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.37%
Min EPS beat(2)-0.02%
Max EPS beat(2)0.76%
EPS beat(4)2
Avg EPS beat(4)-0.03%
Min EPS beat(4)-1.28%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.37%
EPS beat(12)9
Avg EPS beat(12)0.86%
EPS beat(16)13
Avg EPS beat(16)1.11%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-1.04%
Max Revenue beat(2)-0.54%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-1.72%
Max Revenue beat(4)-0.54%
Revenue beat(8)0
Avg Revenue beat(8)-0.91%
Revenue beat(12)2
Avg Revenue beat(12)-0.48%
Revenue beat(16)6
Avg Revenue beat(16)10.64%
PT rev (1m)2.7%
PT rev (3m)8.5%
EPS NQ rev (1m)2.35%
EPS NQ rev (3m)7.42%
EPS NY rev (1m)0%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)1.93%
Revenue NQ rev (3m)6.53%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)2.76%
Valuation
Industry RankSector Rank
PE 27.01
Fwd PE 25.12
P/S 8.86
P/FCF 25.9
P/OCF 25.39
P/B 3.78
P/tB N/A
EV/EBITDA 10.43
EPS(TTM)11.21
EY3.7%
EPS(NY)12.05
Fwd EY3.98%
FCF(TTM)11.69
FCFY3.86%
OCF(TTM)11.93
OCFY3.94%
SpS34.18
BVpS80.11
TBVpS-4.38
PEG (NY)3.59
PEG (5Y)2.51
Graham Number142.15
Profitability
Industry RankSector Rank
ROA 2.03%
ROE 14%
ROCE 26.14%
ROIC 20.13%
ROICexc 22.85%
ROICexgc 233.66%
OM 81.31%
PM (TTM) 32.81%
GM N/A
FCFM 34.21%
ROA(3y)2.34%
ROA(5y)1.97%
ROE(3y)13.02%
ROE(5y)11.7%
ROIC(3y)18.73%
ROIC(5y)14.69%
ROICexc(3y)20.74%
ROICexc(5y)16.19%
ROICexgc(3y)290.88%
ROICexgc(5y)224.49%
ROCE(3y)24.31%
ROCE(5y)19.07%
ROICexgc growth 3Y16.89%
ROICexgc growth 5Y15.23%
ROICexc growth 3Y24.21%
ROICexc growth 5Y29.59%
OM growth 3Y4.02%
OM growth 5Y7.87%
PM growth 3Y-3.77%
PM growth 5Y-4.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.82
Debt/EBITDA 0.33
Cap/Depr 25.23%
Cap/Sales 0.68%
Interest Coverage 73.5
Cash Conversion 41.54%
Profit Quality 104.29%
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.51%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.22%
Profit Quality(3y)104.54%
Profit Quality(5y)102.44%
High Growth Momentum
Growth
EPS 1Y (TTM)9.26%
EPS 3Y12%
EPS 5Y10.74%
EPS Q2Q%9.92%
EPS Next Y7.52%
EPS Next 2Y6.94%
EPS Next 3Y7.53%
EPS Next 5Y4.89%
Revenue 1Y (TTM)20.06%
Revenue growth 3Y19.31%
Revenue growth 5Y19.33%
Sales Q2Q%8.09%
Revenue Next Year7.38%
Revenue Next 2Y6%
Revenue Next 3Y6.11%
Revenue Next 5Y4.78%
EBIT growth 1Y24.41%
EBIT growth 3Y24.1%
EBIT growth 5Y28.72%
EBIT Next Year10.74%
EBIT Next 3Y9.04%
EBIT Next 5Y7.54%
FCF growth 1Y16.6%
FCF growth 3Y12.23%
FCF growth 5Y10.74%
OCF growth 1Y15.89%
OCF growth 3Y11.86%
OCF growth 5Y9.51%

CME GROUP INC / CME Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CME GROUP INC (CME) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CME.


What is the valuation status of CME GROUP INC (CME) stock?

ChartMill assigns a valuation rating of 2 / 10 to CME GROUP INC (CME). This can be considered as Overvalued.


What is the profitability of CME stock?

CME GROUP INC (CME) has a profitability rating of 7 / 10.


Can you provide the financial health for CME stock?

The financial health rating of CME GROUP INC (CME) is 5 / 10.


Can you provide the dividend sustainability for CME stock?

The dividend rating of CME GROUP INC (CME) is 3 / 10 and the dividend payout ratio is 97.81%.